CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-03 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +60,217 | $1.86 | $112K | 112,255 |
| 2024-09-03 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +475 | $3.80 | $2K | 112,730 |
| 2024-09-03 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −59,214 | $26.09 | $1.5M | 53,516 |
| 2024-09-03 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,478 | $27.13 | $40K | 52,038 |
| 2024-09-03 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −60,217 | 0 | ||
| 2024-09-03 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −475 | 44,549 | ||
| 2024-09-03 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +14,000 | $8.83 | $124K | 35,736 |
| 2024-09-03 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +29,730 | $11.10 | $330K | 65,466 |
| 2024-09-03 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +24,776 | $11.97 | $297K | 90,242 |
| 2024-09-03 | Moat Ross CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −67,346 | $26.10 | $1.8M | 22,896 |
| 2024-09-03 | Moat Ross CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −1,160 | $27.12 | $31K | 21,736 |
| 2024-09-03 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Share Option 10b5-1 | −14,000 | 0 | ||
| 2024-09-03 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Share Option 10b5-1 | −29,730 | 18,534 | ||
| 2024-09-03 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Share Option 10b5-1 | −24,776 | 30,924 | ||
| 2024-09-02 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise | +1,964 | 125,052 | ||
| 2024-09-02 | Tessari Eben CHIEF OPERATING OFFICER | Shares withheld for taxes | −577 | $26.74 | $15K | 124,475 |
| 2024-09-02 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit | −1,964 | 1,964 | ||
| 2024-09-02 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise | +775 | 26,764 | ||
| 2024-09-02 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −329 | $26.74 | $9K | 26,435 |
| 2024-09-02 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit | −775 | 774 |
Page 46 of 74 · 1,467 trades